These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 17124193)
1. Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines. Balzarini J; Schols D; Van Laethem K; De Clercq E; Hocková D; Masojidkova M; Holý A J Antimicrob Chemother; 2007 Jan; 59(1):80-6. PubMed ID: 17124193 [TBL] [Abstract][Full Text] [Related]
2. Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines. De Clercq E; Andrei G; Balzarini J; Leyssen P; Naesens L; Neyts J; Pannecouque C; Snoeck R; Ying C; Hocková D; Holý A Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):331-41. PubMed ID: 16247948 [TBL] [Abstract][Full Text] [Related]
3. 6-[2-phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines: a new class of acyclic pyrimidine nucleoside phosphonates with antiviral activity. Balzarini J; Pannecouque C; Naesens L; Andrei G; Snoeck R; De Clercq E; Hocková D; Holý A Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1321-7. PubMed ID: 15571252 [TBL] [Abstract][Full Text] [Related]
4. 5-Substituted-2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidines-acyclic nucleoside phosphonate analogues with antiviral activity. Hocková D; Holý A; Masojídková M; Andrei G; Snoeck R; De Clercq E; Balzarini J J Med Chem; 2003 Nov; 46(23):5064-73. PubMed ID: 14584956 [TBL] [Abstract][Full Text] [Related]
5. Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates. Balzarini J; Pannecouque C; De Clercq E; Aquaro S; Perno CF; Egberink H; Holý A Antimicrob Agents Chemother; 2002 Jul; 46(7):2185-93. PubMed ID: 12069973 [TBL] [Abstract][Full Text] [Related]
6. Antiretroviral activities of acyclic nucleoside phosphonates [9-(2-phosphonylmethoxyethyl)adenine, 9-(2-phosphonylmethoxyethyl)guanine, (R)-9-(2-phosphonylmethoxypropyl)adenine, and MDL 74,968] in cell cultures and murine sarcoma virus-infected newborn NMRI mice. Balzarini J; Vahlenkamp T; Egberink H; Hartmann K; Witvrouw M; Pannecouque C; Casara P; Navé JF; De Clercq E Antimicrob Agents Chemother; 1997 Mar; 41(3):611-6. PubMed ID: 9056002 [TBL] [Abstract][Full Text] [Related]
7. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions. Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155 [TBL] [Abstract][Full Text] [Related]
8. Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge. De Clercq E Biochem Pharmacol; 2007 Apr; 73(7):911-22. PubMed ID: 17045247 [TBL] [Abstract][Full Text] [Related]
9. Structure-antiviral activity relationship in the series of pyrimidine and purine N-[2-(2-phosphonomethoxy)ethyl] nucleotide analogues. 1. Derivatives substituted at the carbon atoms of the base. Holý A; Günter J; Dvoráková H; Masojídková M; Andrei G; Snoeck R; Balzarini J; De Clercq E J Med Chem; 1999 Jun; 42(12):2064-86. PubMed ID: 10377214 [TBL] [Abstract][Full Text] [Related]
10. Antiretroviral activity and pharmacokinetics in mice of oral bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine. Naesens L; Balzarini J; Bischofberger N; De Clercq E Antimicrob Agents Chemother; 1996 Jan; 40(1):22-8. PubMed ID: 8787873 [TBL] [Abstract][Full Text] [Related]
11. The acyclic 2,4-diaminopyrimidine nucleoside phosphonate acts as a purine mimetic in HIV-1 reverse transcriptase DNA polymerization. Herman BD; Votruba I; Holy A; Sluis-Cremer N; Balzarini J J Biol Chem; 2010 Apr; 285(16):12101-8. PubMed ID: 20164190 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiviral activity of N9-[3-fluoro-2-(phosphonomethoxy)propyl] analogues derived from N6-substituted adenines and 2,6-diaminopurines. Baszczyňski O; Jansa P; Dračínský M; Klepetářová B; Holý A; Votruba I; de Clercq E; Balzarini J; Janeba Z Bioorg Med Chem; 2011 Apr; 19(7):2114-24. PubMed ID: 21429755 [TBL] [Abstract][Full Text] [Related]
13. The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase. Andrei G; Gillemot S; Topalis D; Snoeck R J Infect Dis; 2018 Feb; 217(5):790-801. PubMed ID: 29186456 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of novel nucleoside and nucleotide analogues as agents against DNA viruses and/or retroviruses. Hakimelahi GH; Ly TW; Moosavi-Movahedi AA; Jain ML; Zakerinia M; Davari H; Mei HC; Sambaiah T; Moshfegh AA; Hakimelahi S J Med Chem; 2001 Oct; 44(22):3710-20. PubMed ID: 11606136 [TBL] [Abstract][Full Text] [Related]
15. Antiretroviral efficacy and pharmacokinetics of oral bis(isopropyloxycarbonyloxymethyl)-9-(2-phosphonylmethoxypropyl)adenine in mice. Naesens L; Bischofberger N; Augustijns P; Annaert P; Van den Mooter G; Arimilli MN; Kim CU; De Clercq E Antimicrob Agents Chemother; 1998 Jul; 42(7):1568-73. PubMed ID: 9660984 [TBL] [Abstract][Full Text] [Related]
16. 9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivo. Balzarini J; Holy A; Jindrich J; Dvorakova H; Hao Z; Snoeck R; Herdewijn P; Johns DG; De Clercq E Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4961-5. PubMed ID: 1711214 [TBL] [Abstract][Full Text] [Related]
17. Conservation of antiviral activity and improved selectivity in PMEO-DAPym upon pyrimidine to triazine scaffold hopping. de Castro S; Fernández-Cureses G; Andrei G; Snoeck R; Sánchez-Murcia PA; Korba B; Gago F; Balzarini J; Camarasa MJ Antiviral Res; 2015 Oct; 122():64-8. PubMed ID: 26275802 [TBL] [Abstract][Full Text] [Related]
18. Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine. Balzarini J; Holy A; Jindrich J; Naesens L; Snoeck R; Schols D; De Clercq E Antimicrob Agents Chemother; 1993 Feb; 37(2):332-8. PubMed ID: 8452366 [TBL] [Abstract][Full Text] [Related]
20. Activity of the (R)-enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems. Balzarini J; Aquaro S; Perno CF; Witvrouw M; Holý A; De Clercq E Biochem Biophys Res Commun; 1996 Feb; 219(2):337-41. PubMed ID: 8604988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]